Friday 31 March 2017

Empty Capsules Market - An Emerging Worldwide Industry

Global Empty Capsules Market: Overview
The demand for capsules is growing on account of the mounting consumption of medicines worldwide. This trend augurs well for the global empty capsules market, where growth has thus far been driven by the demand for both nongelatin and hard gelatin capsules. The changing demographics of the world have necessitated the greater production of medicines to treat various kinds of diseases. Capsules, being among the most versatile forms of administering drug doses, are thus expected to be consumed in larger volumes over the next few years.
The typical capsule is made from gelatin and encloses either a single medicinal ingredient or a combination of the same. Empty capsules are available in numerous sizes depending on the dosage of medicine to be administered. The use of gelatin to make capsules is most widespread because the material renders several advantages, including but not limited to better stability in various temperature ranges, its odorlessness and tastelessness, and softness, which makes it easy to swallow. However, the market also features capsules made of other nongelatin-based materials.
The demand for empty capsules is expected to rise substantially in the years ahead thanks largely to the overall growth and expansion of the global pharmaceuticals industry. Moreover, the greater demand for nutraceuticals will also provide the global capsules market an opportunity to expand as several food supplements and functional foods are encapsulated to make them convenient for on-the-go consumption.
Global Empty Capsules Market: Trends, Drivers, and Restraints
Because capsules are regarded as a convenient method of consuming health supplements and medication, their demand is likely to grow substantially. Moreover, consumers in developing regions now have higher spending power and thus the ability to allocate more funds toward healthcare and preventative healthcare. Besides the pharmaceuticals and nutraceuticals industries, the demand for encapsulated ingredients is also on the rise in the cosmetics and cosmeceuticals sector. These end-user trends will have a far-reaching influence on the growth of the global empty capsules market.
Although there is no dearth of revenue-generation opportunities in the global empty capsules market, companies will have to brave headwinds in the form of tightening regulatory guidelines and the need for a high initial investment in R&D and manufacturing facilities. Furthermore, in mass markets such as India, where the majority of vegetarian consumers view animal-derived gelatin in a negative light, companies will face the need to find solutions around the problem by focusing more on nongelatin capsules. Overall, globally, the demand for soft gelatin capsules is showing a clear increase, and players are recommended to explore growth avenues in this space.
Global Empty Capsules Market: Region-wise Outlook
The demand for empty capsules is seen to be highest in regions where the pharmaceuticals sector is well developed. Thus, while the developed countries of the west have been the traditional markets for empty capsules, the growing number of pharmaceutical contract research establishments in Asian countries will lead to an increased demand for empty capsules.
The North America empty capsules market leads in terms of revenue share and the outlook for the Asia Pacific empty capsules market remains positive. Europe follows North America in terms of revenue in the global empty capsules market. A number of companies in the empty capsules market are increasingly moving eastward, causing a shift in the market’s dynamics.
Companies that currently rake in the highest revenue in the global empty capsules market are ACG Worldwide, Capsugel, Medi-Caps Ltd, Qualicaps, Inc., CapsCanada Corporation, Bright Pharma Caps, Inc., Suheung Co. Ltd, and Snail Pharma Industry Co. Ltd.

Medical Oxygen Concentrators Market: Consumers Show Greater Preference for Portable Medical Oxygen Concentrators

Medical Oxygen Concentrators Market: Snapshot
The global medical oxygen concentrators market is currently being driven by the rising number of COPD patients across the world. The number of patients suffering from lung cancer, asthma, smoking-related lung disorders, and other respiratory illnesses is also increasing at a swift rate, further boosting the overall demand for oxygen supply units and especially medical oxygen concentrators. These units are also considered more advantageous due to their portability and the fact that they can provide an uninterrupted supply of oxygen. Government reimbursement policies are also being increasingly favorable to the global medical oxygen concentrators market and the adoption rate of these units. The market also credits the increasing geriatric population as one of the leading demographics in need of constant oxygen supply. However, the global medical oxygen concentrators market is being restrained by the large number of oxygen concentrators with continuous flow technology, which essentially waste oxygen and electricity when not in use. The high cost of portable oxygen concentrators is also making it difficult for emerging economies to adopt them at a faster rate.
The global medical oxygen concentrators market is projected to reach US$2.41 bn in 2024. It is expected to expand at a CAGR of 8.5% from 2016 to 2024, and was valued at US$1.25 bn in 2016.
Consumers Show Greater Preference for Portable Medical Oxygen Concentrators
In terms of modality, the global medical oxygen concentrators market is segmented into portable and stationary oxygen concentrators. Portable oxygen concentrators were leading the market in terms of demand in 2015. Portable oxygen concentrators are easy to carry, light in weight, work on rechargeable lithium batteries, and are small in size. They are designed for an individual of any age being able to carry a unit along his/her daily activities while receiving a concentrated supply of oxygen. The technology used in portable oxygen concentrators is largely known as pulse technology. Stationary oxygen concentrators work on continuous flow technology and consequently require a continuous electricity supply. These are generally used by patients during the night or at their homes. Due to the several advantages posited by the use of portable oxygen concentrators, it is expected that they will continue to acquire the leading share in the global oxygen concentrators market during the forecast period.
According to technology, pulse flow technology leads the global medical oxygen concentrators market in terms of growth rate currently. This technology releases concentrated oxygen only when the patient inhales. Thus it does not base itself on continuous working of the oxygen concentrators and reduces overall consumption of power, allowing units with pulse flow technology to work on rechargeable lithium batteries. Among the end users of the global medical oxygen concentrators market, the home care segment has so far been the leading revenue generator.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3998
Geriatric and COPD Population in North America Puts Region in Lead
In terms of geography, the global medical oxygen concentrators market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America contributed the leading volume of demand in the global oxygen concentrators market for 2015, owing to an increasing use of portable oxygen concentrators at home. This region is likely to remain in the lead over the coming years. Europe places second in terms of demand in the global medical oxygen concentrators market, owing to an increasing level of awareness over use of oxygen concentrators over conventional oxygen supply units. Latin America and Asia Pacific collectively contributed to 31.4% of share in the global medical oxygen concentrators market for 2015 and are positioned as high potential locations in terms of untapped regions.
Leading players in the global medical oxygen concentrators market so fat have been Chart Industries, Inc., Inogen, Inc., Invacare Corporation, Koninklijke Philips N.V., Resmed Inc., Drive DeVilbiss Healthcare LLC., Precision Medical, Inc., Besco Medical Co. Ltd., O2 Concepts LLC, and GCE Group.

Vial Adaptors for Reconstitution Drug Market - Positive long-term growth outlook 2016 - 2024

Global Vial Adaptors for Reconstitution Drug Market: Snapshot
The global market for vial adaptors for reconstitution drugs has been experiencing a steady demand as these vial adaptors have come to be the safest solutions for quick transfer for drugs between vials. The demand for these vial adaptors is also expected to shoot up as they are exceptionally cost-effective and come with a reduced the risk of needlestick injuries. The growing prevalence of infectious diseases, widening pool of geriatrics, and increasing safety concerns have all triggered a demand for vial adaptors for reconstitution drugs. According to the research report, the global vial adaptors for reconstitution drug market was valued at US$780 mn in 2015 and is expected to reach US$1.3 bn by the end of 2024. Between the forecast years of 2016 and 2024, the global market is expected to progress at a CAGR of 7.5%.
Autoimmune Diseases to Drive Global Vial Adaptors for Reconstitution Drug Market
On the basis of therapeutic area, the vial adaptors for reconstitution drug market has been segmented into autoimmune diseases, infectious diseases, metabolic conditions, reproductive health and others. Currently, the infectious diseases segment holds a major share in the global vial adaptors for reconstitution drug therapeutic area segment. However, the autoimmune diseases segment is expected to show robust growth rate in the coming years. As of 2015, it was the second largest segment in the overall market in terms of revenue. The American Autoimmune Related Diseases Association (AARDA) states that more than 50 million individuals are affected by autoimmune disorders in the U.S. every year. This is expected to drive the autoimmune diseases segment in the coming years.
North America to Remain the Leading Regional Market during Forecast Period
In terms of geography, the global market is segmented into North America, Europe, Asia Pacific, and Rest of the World. Out of these regional markets, North America remained dominant in the global vial adaptors for reconstitution drug market in 2015. Europe followed this lead closely. The high incidence of autoimmune diseases, rising technological advancements, and growing demand for needle-free products likely to support the growth of the vial adaptors for reconstitution drug market in North America. On the other hand, the demand in Europe will be fueled by increasing advancements in healthcare technology amidst rising safety concerns.
Analysts estimate that Asia Pacific is also likely to be a lucrative market for the vial adaptors for reconstitution drugs during the forecast period. The growing adoption of technology, high prevalence of autoimmune diseases such as diabetes, and increasing adoption of technology are all expected to make a significant contribution to the soaring vial adaptors for reconstitution drug market in Asia Pacific. This regional market will also be propelled by the swelling pool of geriatrics, who are prone to various medical conditions and a vast pool of unmet medical needs. The strengthening economies of Asia Pacific and improving access to healthcare in the region are also likely to augment the demand for vial adaptors for reconstitution drugs.
The key players operating in the global vial adaptors for reconstitution drug market are Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Sensile Medical AG, Unilife Corporation and West Pharmaceutical Services, Inc. The market is largely consolidated as major players hold a dominating share.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

Multiplexed Diagnostics Market is expected to expand at a CAGR of 20% from 2016 to 2024

Global Multiplexed Diagnostics Market: Snapshot
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations. However, the global multiplexed diagnostics market is being restrained by high costs pertaining to multiplexed diagnostics assay equipment and testing and an overall lack of skilled labor for handling the advanced equipment.
The global multiplexed diagnostics market was valued at US$5.0 bn in 2015. It is projected to reach US$26.36 bn by the end of 2024 after expanding at a CAGR of 20% from 2016 to 2024.
North America’s Dominance in Global Multiplexed Diagnostics Market to Continue
The global Multiplexed diagnostics market is segmented on the basis of regions, into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2015, North America bagged for the leading share of the market in terms of value, owing to a rising prevalence of cardiac diseases and cancer in the region. North American players in the multiplexed diagnostics market also benefitted from the greater level of penetration of the national health care services. The region is expected to continue dominating the global multiplexed diagnostics market till 2024, a likelihood attributed to the region’s high percentage of the geriatric population, an advanced and structured healthcare industry, and a large scope of application of reimbursement policies from both public and private sources.
In Europe, the market for multiplexed diagnostics is also expected to grow at a substantial rate with the growing involvement of academic and research institutes from Germany and the U.K. North America and Europe are projected to be highly lucrative markets for players from the global multiplexed diagnostics market. Conversely, multiplexed diagnostics have not yet found solid foundations in Latin America, Asia Pacific, and the Middle East & Africa to grow on for now.
Infectious Disease Diagnostics in Full Swing
In terms of applications, the global multiplexed diagnostics market can be divided into autoimmune diseases, oncology, cardiac diseases, infectious disease diagnostic, and allergies. In 2015, a collective lead was attributed to the two segments of infectious disease diagnostics and oncology, due to an increase in the prevalence of infectious diseases along with a growing count of patients suffering from breast cancer, colorectal cancer, and prostate cancer. Oncology, cardiac diseases, and infectious disease diagnostics are expected to be highly beneficial segments for players from the global multiplexed diagnostics market. The segment for cardiac diseases is expected to expand at leading rate over the coming years due to the growing prevalence of various cardiovascular diseases. In terms of end users, the global multiplexed diagnostics market was led by academic research institutes in 2015. It is also expected to be the dominant end user in the market till 2024, owing to an increasing contribution of universities and cancer research centers and the research projects in the field of genetic engineering.
Till 2015, the leading players in the global multiplexed diagnostics market included Agilent Technologies, Bio-Rad Laboratories, Inc., BioMérieux SA, F. Hoffmann-La Roche Ltd., Illumina, Inc., Luminex Corporation, Hologic, Inc., Thermo Fisher Scientific, Inc., Siemens Healthineers, and Abbott Laboratories.

Technology Spending on Revenue Cycle Management Market: Companies Going for Cloud-based Revenue Cycle Management

Global Technology Spending on Revenue Cycle Management: Snapshot
The global technology spending on revenue cycle management is primarily being driven by the wide array of advantages that their implementation can offer, such as increase in revenue generation, better efficiency in healthcare practices, easier compliance with industry norms and regulations, and greater accuracy and easier access to healthcare IT systems. However, its market is currently being restricted by a host of issues, including the inability to handle uninsured patients, the losses and increased pressure incurred due to changes in regulations, the low mobility of a system in response to shifting market dynamics, and the overall concerns regarding the integrity and security of data.
The current trends in the global market for technology spending on revenue cycle management include a growing use of credit card programs that can aid and cover a greater percentage of a national population and allow healthcare organizations to access their medical data faster. The global market for technology spending on revenue cycle management is expected to reach an evaluation of US$51.56 bn by the end of 2024. It was calculated at US$28.50 bn at the end of 2015 and is expected to expand at a healthy CAGR of 6.9% within a forecast period from 2016 to 2024.
Companies Going for Cloud-based Revenue Cycle Management
Revenue cycle management can be dissected into integrated and stand-alone, on the basis of platforms. An integrated platform for revenue cycle management is a combined system for a healthcare organization’s financial performance management, a patient’s electronic health records (EHR), and business intelligence tools, all collected under a single revenue cycle solution. A stand-alone platform in revenue cycle management, on the other hand, can work independently of other solutions or software. It works individually without requiring patient health records or medical records integration. Based on deployment, revenue cycle management is segmented into cloud-based and on-premise. Cloud-based deployment is trending and has greater growth opportunities in the forecast years due to its accessibility and lower costs.
APAC Grows Stronger in Demand for Revenue Cycle Management
North America played the leading role among all key regions in technology spending on revenue cycle management in 2015. However, over the coming years, technology spending on revenue cycle management in Asia Pacific will exhibit the leading CAGR of 8.5%, between 2016 and 2024. Asia Pacific is therefore expected to hold an important position in the sustainable growth of the global technology spending on revenue cycle management industry over the above forecast period.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17597
The Asia Pacific region is still relatively behind in terms of adoption and development of new technologies. Although the expenditures on technology in modern revenue cycle management is currently low in the region, the market is expected to grow substantially, owing to factors such as the positive modulations in global regulatory reforms, the evolving economic scenario and its consequent increase in purchasing power of consumers and enterprises, growing awareness of the advantages of modern revenue cycle management processes and the presence of a large and growing number of patients suffering from various chronic disorders. Japan currently represents a highly lucrative market in terms of spending, compared to the rest of the APAC nations.
Cerner Corporation, McKesson Corporation, DST Systems, Inc., Allscripts, 3M, and Perot Systems have been some of the key players that have led the global market in technology spending on revenue cycle management. A large number of the more prominent entities from this market are known to be located within the U.S.

Photopheresis Products Market is expected to rise to US$ 371.1 mn by 2024

As autoimmune disease become increasingly prevalent across the world, researchers are keeping no stone unturned to find the most effective cure. Photopheresis has emerged as one of the most promising treatment options for autoimmune diseases, solid organ transplant rejection, chronic graft versus host diseases, and advanced cutaneous T-cell lymphoma. The treatment was first approved by the FDA in 1988 and is largely considered is the first line of therapy administered in case of aforementioned conditions. Photopheresis offers a range of benefits such as better efficacy and lesser side effects compared to other drug treatments. While this will create lucrative prospects, the market is also expected to gain from the increasing demand for blood derived products.
According to Transparency Market Research (TMR), the global photopheresis product market is expected to report a CAGR of 5.9% between 2016 and 2024. At this pace, the market will reach US$371.1 mn by the end of 2024, from a valuation of US$223.1 mn in 2015.
Q: How the future of the global photopheresis products market looks like?
A: Government bodies across the world are encouraging patients to undergo external counter pulsation (ECP) therapy, in the form of favorable reimbursements, for the treatment of various diseases. These policies and the consequent coverage of medical expenses covered under government-supported refunds are encouraging patients towards choosing the therapy for the treatment of various ailments.
Furthermore, globally the incidence of cutaneous T-cell lymphoma (CTL), which is a rare non-Hodgkin lymphoma affecting skin, is increasing. As per the Cutaneous Lymphoma Foundation, every nearly 1500 new cases of (CTL) is reported in the U.S. As the incidence continues to increase, experts are recommending ECP as the first line of therapy despite the availability of various therapies for the treatment of CTL. These factors are indicative of a promising future of the global photopheresis products market.
Q: Which regions will show most lucrative opportunities for the market?
Regionally, North America dominates the global photopheresis products market. It held over half of the global market in 2015 and is projected to retain its dominance through the course of the next few years. Favorable reimbursement policies for various disease indications such as CTL and lung transplantation by ECP have been providing significant impetus to the market in North America. For instance, in 2012, Medicare extended their reimbursement coverage for ECP for the treatment of bronchiolitis obliterans syndrome (BOS). Furthermore, various such policies are underway, which are expected to provide boost to the photopheresis products market in North America.
On the down side, inadequate availability of treatment centers for ECP therapy is likely to slow the pace of gains for the market. Nevertheless, the region boasts comparatively more number of positive factors indicative of a promising future for the market. As per TMR, the North America photopheresis market is expected to show a 5.8% CAGR between 2016 and 2024.
Meanwhile, the Asia Pacific market which held only 4% of the global photopheresis products market in 2015, is poised to exhibit the leading CAGR of 6.6% during the same forecast period. The visibly increasing investment in the healthcare sectors across the region’s most promising economies has resulted in the rise in number of photopheresis centers in the region. Faster regulatory approvals and emergence of corporate entity in the ECP sector is promoting the growth of the region’s photopheresis products market.

Thursday 30 March 2017

Developments in Artificial Skin to Dictate Global Skin Replacement Market’s Growth

A new research report presented by Transparency Market Research discusses the market drivers and restraints for the global skin replacement market. The research report, titled “Skin Replacement Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024,” provides a detailed explanation of the various trends and dynamics set to define this market in the near future. For a holistic outlook, the researchers have studied the strengths, weaknesses, opportunities, and threats faced by the segments of the global skin replace market.
The report states that skin, being the largest organ of the body, also forms a protective layer over the organs. However, it can also be easily damaged due to constant exposure to pollutants, irritants, bacteria, and viruses amongst others. In order to rectify severe skin-related issues, patients opt for skin replacement to restore its normal function.
Immense progress made by dermatologists in developing artificial skin has played a vital role in driving the global skin replacement market. The increasing research and growing investments to introduce novel products are also expected to boost this market in the coming years. Emerging economies and the rising disposable incomes are also responsible for the remarkable growth of the global skin replacement market.
The report segments the global skin replacement market on the basis of end user and material. The end users of artificial skin are chemical, pharmaceutical, and cosmetic sectors. The materials used for creating this skin are spider silk and collagen. Geographically, this market is segmented into North America, Europe, Asia Pacific, and Rest of the World.
Analysts predict that North America holds a leading spot in the overall market as it contributes significant revenues. However, the scenario is about to change gradually as Asia Pacific is poised to emerge as a leader with support from medical tourism industry that is offering lucrative packages to global patients seeking skin replacement solutions. The report states that the global skin replacement market will tremendously benefit from bioengineered skin replacements as they have the unique ability to function like actual skin. However, this ingenious solution will face a tough challenge from other competitively priced substitutes.
Some of the important players operating in the global skin replacement market are TissueGene, Inc., Platelet BioGenesis, Cynata Therapeutics Limited, Tengion, and Cellular Dynamics International. The research report profiles these players and provides a comprehensive analysis of the competitive landscape in the global skin replacement market. Furthermore, it also assesses the financial outlook, investment overview, research and development strategies, business and marketing strategies, and strategic mergers and acquisitions of these key players in the global skin replacement market in the coming years.

Veterinary Laboratory Testing Services Market Set to Expand by 2024

Veterinary Laboratory Testing Services Market: Overview
Veterinary laboratory testing is referred as the test that is performed for the detection of disease in an animal. The veterinary clinical laboratory industry looks similar to human counterparts. Nearly all the modern clinical laboratory instrument and technologies are widely utilized in the veterinary laboratory marketplace. Compared to human laboratory testing the veterinary laboratory testing market is very daunting. Service level in veterinary laboratory testing market is more challenging as compared to human laboratory industry. Veterinarians are rarely asked to routine laboratory examination for the animals. When veterinarians refer a specimen to a laboratory it signifies that the treated animal is in a critical condition or in a life threatening situation.
Veterinary Laboratory Testing Services Market: Segmentation
The global market for veterinary laboratory testing can be segmented as:
By Method Types
  • ELISA/cELISA
  • Lateral flow tests
  • IFA/IFAT
  • Complement fixation
  • Agglutination
  • Tuberculosis testing
  • Western blot
  • Molecular tests
  • PCR/qPCR
  • Microarrays/Biochips
  • Blots
  • Clinical chemistry
  • Hematology
  • Assay validation
Assay validation and reference range establishment is a very challenging task in human clinical laboratory while the same task can be done easily in veterinary laboratory. Most of the modern instruments used in clinical laboratories are readily utilized in veterinary laboratories in recent times.
Veterinary Laboratory Testing Services Market: Trends and Drivers
Globally, daily disposable income of an individual is increasing rapidly. Thus, the adoption rate of dogs and cats is increasing significantly with increasing disposable income of the global population. Likewise, with increasing adoption rate of dogs and cats the global market for veterinary laboratory testing will also increase. Moreover, prevalence of zoonotic diseases is on the rise among global population. Thus, it is necessary to perform routine examination laboratory test for pet animals.
Moreover, with the rising prevalence of zoonotic diseases the global market for veterinary laboratory testing services will also increase. The cost is very high for veterinary diagnostic product and services is a factor that would restrict the global market demand of veterinary diagnostic testing services market to some extent. Moreover, lack of awareness about veterinary laboratory testing in few of the developing nations is also a factor that might restrict its demand in the global veterinary laboratory testing services market.
Veterinary Laboratory Testing Services Market: Regional Overview
Geographically, North America dominates the global market for veterinary laboratory testing services due to increasing demand for laboratory based diagnostic test for animals. Moreover, increasing awareness among people about laboratory based diagnostic for pet animals will also accentuate the market in North American region.
Europe represents the second position in the global market due to technological advancement and increasing awareness among people. Asia–Pacific is considered as an emerging market in the global veterinary laboratory testing services market due to large number of animals (cow, buffalo and goat) suffering from various diseases.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11534
Moreover, the market for veterinary laboratory testing services is at its initial stage in Asian countries. Thus, it is expected that Asia–Pacific will contribute a significant market share during the forecast period. Rest of the World (RoW) region is considered as an untapped market in the global veterinary laboratory testing services market.
Veterinary Laboratory Testing Services Market: Key Players
Major market players contributing the global market share of veterinary laboratory testing services include Heska Corporation, Life Technologies Corporation, Pfizer Animal Health, IDEXX Laboratories Inc., Prionics AG, Abaxis Corporation and Other Market Participants.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Institutional Pharmacies Market: Applications and Global Markets

Institutional Pharmacies Market: Overview

Pharmacies, or pharmaceutical shop is a kind of shop which is engaged in the selling and distribution of pharmaceutical and healthcare related products (drugs, devices and others) and services (dosing training, medical advice, information about side effects and precautions) to the patients and customers. Pharmacy shop is an inseparable aspect of pharmaceutical sciences field and is one of the most growing field in the healthcare industry.

Pharmacies are broadly classified on the basis of sales nature and end customers, namely, retail pharmacy and institutional (consultant) pharmacy. Retail pharmacies comprises traditional, independent pharmaceutical shops, which are engaged in satisfying the customer needs and interaction with routine customers, whereas, institutional pharmacies offer more emphasis on provision of long-term care facilities, products and services, and on maintenance of patient data and medication history and records.

Although, the institutional pharmacies were not directly involved in patient interaction, due to rising geriatric population and changes in the pharmacy practices, institutional pharmacies have started consulting and guiding the patients directly. Sometimes, institutional pharmacies are considered similar to hospital pharmacies, but former is different on the basis of principles of operating the business and end users.


Institutional Pharmacies Market: Drivers and Trends

The market of institutional pharmacies is expected to grow steadily in upcoming period, owing to various market drivers, such as, benefits of bulk purchase, increased need of institutional pharmacies, rise in geriatric population where patient data monitoring has became essential. In addition, rising prevalence of chronic disease propelling the needs of long-term care, large employment opportunities and rising awareness amongst the pharmaceutical graduates and hospitals regarding the benefits of institutional pharmacies against the traditional pharmacies. Rising geriatric population and chronic disease prevalence are some of the most important drivers of this market.

According to Center for Disease Control and Prevention (CDC), by the 2050, the aged population in the U.S. would exceed 89 million, twice of the 2013. Institutional pharmacies play an important role in maintaining the clinical database and guiding the geriatric patients regarding medications and its associated issues.

Further, increased prevalence of chronic disease is another growth propeller of the institutional pharmacies. According to International Diabetes Federation, 382 million people across the globe are suffering from diabetes, by 2013, and this number is expected to grow to 592 million by the end of 2035.

Institutional Pharmacies Market: Restraints

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11522

The institutional pharmacies play a vital role in the maintenance of patient medication database related to such chronic diseases and helps in the estimation of further treatments. On the other hand, lack of awareness, high initial costs and stringent government regulations are the major hurdles, expected to impose a threat to the market growth. In addition to this, shrinking medical reimbursement and increasing consolidation of the industry are additional threats to the market growth. The major opportunities include government programmes and campaigns for the promotion of this concept in the world, regulation of laws and rules related to institutional pharmacies would enhance the institutional pharmacies across the globe.

Institutional Pharmacies Market: Key Players

Major players operating in this market include OmniCare, PharMerica, BGS Pharmacy Partners, Golden Horizons, NuScriptRx, Uvanta, Chem Rx Corporation and others. Due to extensive trend of consolidation of the industry, many major players are employing the strategies of acquisitions and partnerships to expand their product portfolio and geographic presence. For instance, Chem Rx Corporation formed partnership with PharMerica to expand the business in New Jersey and New York, U.S. Similarly, BGS Pharmacy Partners acquired Spectrum Pharmacy Services, LLC, to expand the business in Las Vegas, U.S.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

Real-Time E-Healthcare System Market 2016-2024 Industry Size, Shares and Research Trends

Global Real-Time E-Healthcare System Market: Overview
Even as the healthcare sector undergoes a transformative change from paper-based to digital healthcare records, TMR predicts greater change in this space with the advent of real-time e-healthcare systems. Both patients and healthcare providers are feeling the need to have access to healthcare records in real time. This has led software developers and IT solutions providers to respond via the development of real-time healthcare records and systems.
Simply stated, a real-time e-healthcare system is a digital health platform that allows instant access to healthcare records at any time and from any location. This enables constant communication between medical practitioners and their patients. Health conditions can be monitored more closely and efficiently. The latest generation of real-time e-healthcare systems has gone a step further by allowing patients to check their healthcare records against pre-set parameters to reduce dependence on a third party when doing so.
The unmatched degree of user friendliness afforded by real-time e-healthcare systems will thus prove to be the greatest driver for this market. This will help the market register a very healthy rate of growth, states the report.
Global Real-Time E-Healthcare System Market: Developments, Drivers, and Restraints
The market already features software products such as AccuMed, iPatientCare EHR, e-MDs Chart, and WEBeDoctor that interact with patients for functions ranging from reminding them to take their prescribed medication to notify patients about changes in their health parameters. Since human doctors cannot possibly work so closely with their individual patients, real-time e-healthcare systems are fast filling a void that has existed in the healthcare sector. Community health centers in the U.S. are already experiencing the benefits of deploying real-time e-healthcare systems to improve the quality of healthcare extended to patients.
However, as profitable as this space is turning out to be, it is not without its share of risks. Data breach and computational errors are two grave concerns that companies in the real-time e-healthcare system market need to work around. Moreover, the high cost of maintaining and upgrading such systems could work against their popularity.
Despite these concerns, consumers are expected to have a positive opinion of real-time e-healthcare systems, attracted to their convenience. The growing consumer spending on healthcare facilities, a spiraling use of mobile devices, the demand for home healthcare, and the increasing adoption of integrated healthcare systems on the whole are expected to prove advantageous to this market’s growth. With their initial bugs fixed, real-time e-healthcare systems now make negligible errors and their improve reliability with inspire confidence among consumers.
Global Real-Time E-Healthcare System Market: Important Segments
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11399
The report segments the global e-healthcare systems market basis product type, geography, and end user. The types of products via which real-time e-healthcare systems can be accessed by or connected to consumers include: mHealth applications, fitness bands, thermometers, blood glucose monitors, and clip-on monitoring devices. Geographically, the key segments of this market are: North America, Asia Pacific, Europe, and Rest of the World. Of these, North America currently represents the largest market for real-time e-healthcare systems. However, Asia Pacific is showing great potential as a profitable market for such systems; the region is expected to register a remarkable rate of growth.
Similarly, by end-user, the market can be segmented into: Individual users, pharmacies, hospitals (public or private).
The market is emerging as an intense competing ground for companies in the healthcare IT industry. Larger companies are acquiring start-ups and niche market players to strengthen specific areas in their portfolios. The companies that currently boast a stronghold in the market are: Medtronic, Fitbit, Jawbone, Garmin, DexCom, Misfit Wearables, GE Healthcare, and Cerner Corporation.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Global Report on Oxytocic Pharmaceuticals Market

Global Oxytocic Pharmaceuticals Market: Overview
Dubbed the “love hormone,” oxytocin is a female reproductive hormone, produced in the hypothalamus and released into bloodstream during childbirth. This hormone induces labor and milk production in a lactating mother. Oxytocic drugs can be used as uterotonic for induced labor and to reduce the chances of hemorrhage post C-section. Besides this, oxytocic drugs are also administered in conditions such as post-mature birth; uterine atony; pre-eclampsia, which means hypertension during pregnancy; stillbirth; postpartum hemorrhage; and as an adjunct therapy for treatment of autism and in cases of incomplete abortion.
Apart from being administered to humans, oxytocic drugs are also used as veterinary medications. Oxytocin demonstrates its effect after delivery, during childbirth, and toward the end stage of pregnancy.
According to the World Health Organization, every year more than 15 million babies are born prematurely, and this number of preterm births is expected to increase in the coming years. As per the findings of the National Center for Health Statistics, the U.S. alone exhibited a 23.3% labor induction rate in 2012. Considering these statistics, the demand for oxytocic drugs is expected increase significantly in the near future.
The report provides a comprehensive overview of the global oxytocic pharmaceuticals market. It presents insights into the factors influencing the market’s trajectory. The impact of the prevailing demand and supply trends on the market operations is also examined in the report in detail.
Global Oxytocic Pharmaceuticals Market: Key Opportunities and Threats
The increasing incidence of preterm births and the rising rates of labor induction are the primary factors fuelling demand from the global oxytocic pharmaceuticals market. The rising cases of pregnancy-related complications emerging in developing nations also translate into the increased use of oxytocic drugs. Additionally, the market is also expected to gain from the expansion of the health care and pharmaceutical industries in developing countries. However, awareness regarding the side effects related to oxytocic drugs can hamper their use to an extent, thereby restraining the global oxytocic pharmaceuticals market.
Leading brands offer numerous oxytocic products. Pitocin, Octocin, Evatocin, Syntocinon, Pitogin, Duratocin, Cytotec, and Tiacinon are the most popular brands competing for a larger share of the global oxytocic market. However, the synthetic oxytocin derivatives segment is poised to hold the largest share in the market owing to its easy availability. Likewise, hospitals are expected to emerge as the major end-use sector in the market.
Global Oxytocic Pharmaceuticals Market: Region-wise Outlook
Regionally, North America has been exhibiting the highest demand for oxytocic pharmaceuticals due to the high prevalence of induced labor in the region. Europe is expected to emerge as the second-largest market for oxytocic pharmaceuticals due to the rise in oxytocin administration in response to the increasing number of elective caesareans. The market is also anticipated to gain from the increasing case of C-sections in countries in Asia Pacific, such as India and China.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11342
Global Oxytocic Pharmaceuticals Market: Vendor Landscape
To study the prevailing competitive landscape of the market, the report profiles companies such as APP Pharmaceuticals, LLC, LBS Labs, Baxter Healthcare Corporation, JHP Pharmaceuticals, LLC, and Pfizer Inc. The report studies these companies based on their business strategies, financial overview, and product portfolio. The strengths and weaknesses of these enterprises are analyzed. The report also presents in-depth overview of the threats and opportunities that these companies are expected to face during the forecast period.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Wednesday 29 March 2017

Patient Transport System Market: Industry Overview and Key Factors

Patient transport system enables and ensures on time delivery of medically ill, injured patients to health care organizations/institutions. Patient transport systems with significant resources and experienced staff have become an important and integral part of the health care sector. These systems are required by both critically ill, acute, chronic and non-urgent, planned patients for transport to and from hospitals, rehabilitation centers, clinics, nursing homes, and patient’s home. A patient transport system can be classified into two categories: emergency patient transport system and non-emergency patient transport system. The patient transport system market has experienced significant growth in the past few years and is expected to grow at a higher rate driven by increasing emphasis on improving value chain in the health care sector.
The global patient transport system market has been segmented into emergency patient transport system and non-emergency patient transport system. Emergency patient transport system has been further segmented into ground ambulance services, air ambulance services, and water ambulance services. Based on equipment required during transportation, nature of injury and illness, the patient transport system market has been classified into advanced critical life support ambulance, basic life support ambulance, neonatal ambulance, cardiac ambulance, mobile dialysis ambulance, mobile delivery vans, mobile operation theatres, and air ambulances. Non-emergency transport system provides trips to and from scheduled medical appointments, interdepartmental transfers, and transfers between hospitals. It includes basic life support ambulances, wheelchairs, stretchers, first responder services (two wheelers), mobile beds, etc. In developed countries such as the U.S. and countries in Europe air ambulance, advanced critical life support ambulance, neonatal ambulance, and cardiac ambulance will grow at higher rates as compared to other segments.
Advancement of technology in patient transport system, high demand for safety features, increasing pressure for shortest call response time, and increasing number of cardiac, neonatal, and road accident patients are expected to drive the global patient transport system market. Demand for specialty ambulances for neonatal, cardiac, and gynecology patients is expected to be the key driver of the global patients transport system market. Air ambulance system plays a crucial role in minimizing time for transportation especially from remote locations. Government policies on meeting quicker health care facilities especially in remote areas are also anticipated to contribute to the growth of the global patient transport system market. Increasing number of chronic patients globally, growing emphasis on safety and quality features, upcoming technology with ease of access and improved comfort level, and government policies and regulations in non-emergency medical transport have triggered the growth of the non-emergency patient transport segment. Rising cost of technology and safety standards in non-emergency patient transfer especially in developing countries are the key restraints of the segment.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19217
Geographically, the global patient transport system market has been segmented into five regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America and Europe are the major markets for patient transport system owing to high expenditure on health care services and advancement of technologies. According to Wall Street Journal blog, countries such as the U.S., China, and Australia were able to transport 75% of seriously injured road accident patients to hospital, whereas this rate was only 10% to 49% in India, Japan, and Pakistan. This blog highlights the scope and opportunity for the growth of patient transport system in Asia Pacific, the Middle East, and Africa. The market in Asia Pacific is expected witness the highest growth rate due to increasing number of road accidents, rising number of patients, incremental growth in the health care sector, and growing pressure to shorten the call response time.
Key players providing patient transport systems are National Medtrans Network, Falck A/S, Air Methods Corporation, Envision Healthcare Corporation, Acadian, NSL Limited, Airmed International LLC, and Airpal, Inc. Falck A/S dominated the emergency patient transport market with expansion plan in Asia Pacific, while NSL Limited is largest private non-emergency ambulance service provider in the U.K.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Bone Cancer Market is Expected to Witness Highest Growth During 2016 - 2024

One of the most fatal and chronic disorder now a day is Cancer. It is a highly hazardous disease with an extremely high mortality rate due to its highly invasive nature and prolonged duration of disease. Bone cancer is one the types of cancer in which the tissues of bone start growing in uncontrollable manner. This growth can be benign or malignant. In most of the cases, the bone cancer is a result from other cancers.
The major and primary symptom of the bone cancer is severe and intolerable bone pain. This pain increases over the period of time. In addition to pain, symptoms like weight loss, fatigue, bone crack, fever, muscle pain, osteoporosis, and osteopenia are also identified. The diagnostic tests may preliminary include deep study of patient’s history and reasons of pain. Afterwards, the diagnosis of the bone cancer is carried out by using some imaging studies, such as, CT scan, MRI, bone scanning, and PET scanning. Biopsy test is also used for the diagnosis and confirmation of the disease.
Bone cancer market: Segmentation
The market of bone cancer is segmented on the basis of types of bone cancer, such as, primary bone cancer and secondary bone cancer. Primary bone cancer is the type of cancer that originates from rapid and uncontrollable growth of the bone and related tissues. Whereas, secondary cancer is a type of bone cancer, in which, the cancer is originated to some other site of the body and metastasize to the bone structure. The bone cancer is also classified as, osteosarcoma, Ewing’s sarcoma, chondrosarcoma, chordomas, fibrosarcoma, and admantinomas.
Bone cancer market: Types of therapies
the market is also segmented on the basis of therapies and treatments available, such as radiation therapy, chemotherapy, cryosurgery and surgical treatments. Limb amputation surgery, limb salvage surgery or limb sparing surgery are the major surgical practices used to treat bone cancer. Whereas, in radiation therapy, high energy X-rays or gamma-rays are used to destroy the tumors. Chemotherapy is a pharmacological treatment by using anti-cancer drugs either orally or parenterally. Major drugs include strontium-89 chloride, bisphosphonates, methotrexate, denosumab, doxorubicin and many others. Cryosurgery is also sometimes used to treat the bone cancer. In addition, the market is segmented on the basis of geography, such as North America, Europe, Asia-Pacific and Rest of the World (RoW). The North American region is the most dominating market in the world, owing to rapidly growing incidences of bone cancers and rising focus towards R&D for bone tumor treatments. On the other hand, Asia-Pacific and RoW regions are the most promising markets in the upcoming period, owing to rise in awareness of bone cancer, its chronic impacts and its treatments.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14948
Bone cancer market growth
Although it accounts for much less than one percent of all cancers, the market of bone cancer is expected to grow at a steady rate during the forecast period from 2016 – 2024. This growth is anticipated to be driven by various factors, such as, R&D practices running across the globe, rising awareness amongst the population for bone cancer and other bone diseases, increasing medical infrastructure and technological advancements. Owing to R&D practices, a number of drugs and formulations are under pipeline studies and are expected to enter in the market during forecast period. However, low prevalence of the disease is the major hurdle in the market growth, followed by high cost of R&D, diagnosis and treatment.
According to American Cancer Society estimates, approximately 3,300 new cases of bone cancer are expected to diagnose in 2016, out of which, around 1490 deaths are expected due to bone cancer. Hence, this very low prevalence is the major hurdle in the market growth.
The major players operating in this market include Amgen, Inc., Actavis plc, Novartis International AG, Debiopharm Group, Pfizer, Inc., and Eli Lilly and Company amongst others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Separation Systems for Commercial Biotechnology Market is Expected to Rise at a Remarkable CAGR During 2015 - 2023

According to a new market report published by Transparency Market Research “Separation Systems for Commercial Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023”, the separation systems for commercial biotechnology market was valued at US$ 10,665.5 Mn in 2014 and is projected to expand at a CAGR of 6.8% from 2015 to 2023 to reach US$ 19,227.8 Mn in 2023.
Separation systems enable extraction, separation, and purification of a wide range of products and has wide applications in the biotechnology industry. This report studies the global separation systems for Commercial Biotechnology market based on various parameters such as product type, application, and the major geographic markets. Technological advancements would act as a high impact driver of the market. Separation systems such as flow cytometers, chromatography systems, microarray instruments, and membrane filters are likely to propel the market due to high technological developments.
Chromatography systems have gained widespread popularity with the introduction of novel technologies in chromatographic instruments and consumables. Technological advancements in fluorescent labeling and detection methods have offered significant advantage in data, quality, speed, and user safety for microarray based assays.
Liquid chromatography systems held the majority share of the market in 2014, followed by membrane filters. The others segment (biochips, lab-on-a-chip, etc.) has been identified as the fastest growing segment during the forecast period due to its application in point-of-care diagnostic applications as well as in drug discovery and development.
Based on application, the life sciences research and diagnostics segment accounted for over 42.0% share of the global separation systems for commercial biotechnology market in terms of revenue in 2014. Moreover, the segment is expected to gain market share and emerge as the fastest growing segment during the forecast period. Growth of the proteomics market has consequently driven the equipment and supplies market in life sciences research and diagnostics.
Europe was the largest market for separation systems for commercial biotechnology in 2014, accounting for around 29.3% share. The key factor driving the growth of the Separation systems market in Europe is the consistent efforts of various domiciled organizations for the development of chromatography. On the other hand, Asia Pacific is expected to gain significant market share during the forecast period due to high government support for research and in development of the biotechnology industry.
Fill the form for an exclusive sample of this report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2104
Danaher Corporation, Thermo Fisher Scientific, Inc., Waters Corporation, Becton, Dickinson and Company, GE Healthcare, and Merck KGaA are the major players operating in the global separation systems market.
The global separation systems for commercial biotechnology market has been segmented as follows:
Global Separation Systems for Commercial Biotechnology Market, by Product Type
  • Centrifugation Systems
  • Liquid Chromatography
  • Electrophoresis Units
  • Membrane Filters
  • Flow Cytometry
  • DNA Microarray
  • Protein Microarray
  • MACS & FACS Systems
  • Others (biochips, lab-on-a-chip, etc.)
Global Separation Systems for Commercial Biotechnology Market, by End User
  • Life Sciences Research
  • Pharmaceuticals
  • Food & Cosmetics
  • Agriculture
  • Energy
Global Separation Systems for Commercial Biotechnology Market, by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America
    • Middle East & Africa
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453